Home » Uncategorized » Corbevax, Covovax, Molnupiravir Approved For Restricted Emergency Use
Corbevax, Covovax, Molnupiravir Approved For Restricted Emergency Use

Corbevax, Covovax, Molnupiravir Approved For Restricted Emergency Use

Central Drugs Standard Control Organisation (CDSCO) on Tuesday gave emergency use authorization approval to Covovax and Corbexvax covid – 19 vaccines along with anti-viral drug Molnupiravir in a single day, Health Minister Mansukh Mandaviya said. “All these approvals will further strengthen the global fight against the pandemic,” he added.

India’s Omicron cases went up to 653 on Tuesday, with the highest being reported from Maharashtra at 167, followed by Delhi with 165 cases, Kerala 57, Telangana 55 and Gujarat at 49. Meanwhile, the country recorded 6,358 new covid-19 infections in the last 24 hours. Active cases currently stand at 75,456 while the recovery rate is at 98.90 percent.

Ahead of the January 10 rollout of Covid-19 shots for teens, the Union Health Ministry has announced that Bharat Biotech’s covaxin will be the only vaccine that will be administered to eligible recipients in the age group of 15-18 years. The ministry also announced on Monday that the three priority groups of healthcare workers, frontline workers, and individuals older than 60 can receive their third “precautionary dose” 39 weeks after getting their second jab.

With Omicron threat looming over the festive season, Kerala became the latest state to impose a night curfew from 10 pm to 5 pm starting from December 30 till January 2.

Reference : IndianExpress

Thanks for the comment

Social Media Auto Publish Powered By : XYZScripts.com
%d bloggers like this: